Biolargo Stock Market Value
| BLGO Stock | USD 0.29 0.01 3.33% |
| Symbol | BioLargo |
BioLargo 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioLargo's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioLargo.
| 12/22/2024 |
| 01/21/2025 |
If you would invest 0.00 in BioLargo on December 22, 2024 and sell it all today you would earn a total of 0.00 from holding BioLargo or generate 0.0% return on investment in BioLargo over 30 days. BioLargo is related to or competes with Asahi Kaisei, ASP Isotopes, Ganfeng Lithium, Shin-Etsu Chemical, Lsb Industries, Braskem SA, and Tronox Holdings. BioLargo, Inc. invents, develops, and commercializes various platform technologies More
BioLargo Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioLargo's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioLargo upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.62 | |||
| Information Ratio | 0.0908 | |||
| Maximum Drawdown | 24.39 | |||
| Value At Risk | (5.26) | |||
| Potential Upside | 11.11 |
BioLargo Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioLargo's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioLargo's standard deviation. In reality, there are many statistical measures that can use BioLargo historical prices to predict the future BioLargo's volatility.| Risk Adjusted Performance | 0.0889 | |||
| Jensen Alpha | 0.5224 | |||
| Total Risk Alpha | 0.3921 | |||
| Sortino Ratio | 0.076 | |||
| Treynor Ratio | 66.15 |
BioLargo Backtested Returns
BioLargo appears to be out of control, given 3 months investment horizon. BioLargo secures Sharpe Ratio (or Efficiency) of 0.0962, which signifies that the company had a 0.0962 % return per unit of risk over the last 3 months. By analyzing BioLargo's technical indicators, you can evaluate if the expected return of 0.53% is justified by implied risk. Please makes use of BioLargo's Mean Deviation of 3.54, risk adjusted performance of 0.0889, and Downside Deviation of 6.62 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, BioLargo holds a performance score of 7. The firm shows a Beta (market volatility) of 0.0079, which signifies not very significant fluctuations relative to the market. As returns on the market increase, BioLargo's returns are expected to increase less than the market. However, during the bear market, the loss of holding BioLargo is expected to be smaller as well. Please check BioLargo's treynor ratio, as well as the relationship between the semi variance and rate of daily change , to make a quick decision on whether BioLargo's price patterns will revert.
Auto-correlation | -0.68 |
Very good reverse predictability
BioLargo has very good reverse predictability. Overlapping area represents the amount of predictability between BioLargo time series from 22nd of December 2024 to 6th of January 2025 and 6th of January 2025 to 21st of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioLargo price movement. The serial correlation of -0.68 indicates that around 68.0% of current BioLargo price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.68 | |
| Spearman Rank Test | 0.22 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
BioLargo lagged returns against current returns
Autocorrelation, which is BioLargo otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BioLargo's otc stock expected returns. We can calculate the autocorrelation of BioLargo returns to help us make a trade decision. For example, suppose you find that BioLargo has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
BioLargo regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BioLargo otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BioLargo otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BioLargo otc stock over time.
Current vs Lagged Prices |
| Timeline |
BioLargo Lagged Returns
When evaluating BioLargo's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BioLargo otc stock have on its future price. BioLargo autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BioLargo autocorrelation shows the relationship between BioLargo otc stock current value and its past values and can show if there is a momentum factor associated with investing in BioLargo.
Regressed Prices |
| Timeline |
Other Information on Investing in BioLargo OTC Stock
BioLargo financial ratios help investors to determine whether BioLargo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioLargo with respect to the benefits of owning BioLargo security.